Status:
COMPLETED
Prednisone for Heart Failure Patients With Hyperuricemia
Lead Sponsor:
Hebei Medical University
Conditions:
Heart Failure
Hyperuricemia
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
Hyperuricemia is a very common finding in patients with heart failure. It is usually related to diuretic use and deteriorated renal function. The recently evidence showed that uric acid (UA) lowering ...
Eligibility Criteria
Inclusion
- 18-70 years old
- NYHA Class III-IV
- EF =\< 40%
- Uric acid =\> 9.5 mg/dL
Exclusion
- Acute gouty arthritis
- Any condition (other than CHF) that could limit the use of prednisone or allopurinol
- Any concurrent disease likely to limit life expectancy.
- Active myocarditis, or an obstructive or restrictive cardiomyopathy
- Heart Attack, Stroke, Unstable Angina or Cardiac surgery within previous 3 months
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2010
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00919243
Start Date
February 1 2009
End Date
August 1 2010
Last Update
September 1 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kunshen Liu
Shijiazhuang, Hebei, China, 050031